rash at injection site of tirzepatide Injection Site Itching with Tirzepatide:

Any such injectable treatments would be recommended only after a thorough medical assessment and are subject to regulatory requirements in Singapore

Eligibility depends on medical history

Tirzepatide (dual GLP-1/GIP agonist) demonstrates greater mean weight loss1421% across trialsbut with similar individual variability

Monitoring Mental Health During Treatment Initial Assessment and Regular Monitoring When it comes to managing mental health risks associated with semaglutide and tirzepatide, careful monitoring is a must

Devika Umashanker was responsible for data interpretation and analysis, drafting/revising the manuscript, and reviewing/approving the final version for submission